These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 4711847

  • 1. Hyperkalemic cardiac arrhythmia secondary to spironolactone.
    Pongpaew C, Songkhla RN, Kozam RL.
    Chest; 1973 Jun; 63(6):1023-5. PubMed ID: 4711847
    [No Abstract] [Full Text] [Related]

  • 2. [A successfully treated case of spironolactone-induced hyperkalemic quadriplegia].
    Radó J, Csabuda M.
    Orv Hetil; 1985 Aug 11; 126(32):1967-70, 1973-4. PubMed ID: 2993981
    [No Abstract] [Full Text] [Related]

  • 3. Iatrogenic hyperkalemic paralysis with electrocardiographic changes.
    Kalbian VV.
    South Med J; 1974 Mar 11; 67(3):342-5. PubMed ID: 4814187
    [No Abstract] [Full Text] [Related]

  • 4. Hyperkalemia with cardiac arrhythmia. Induction by salt substitutes, spironolactone, and azotemia.
    Yap V, Patel A, Thomsen J.
    JAMA; 1976 Dec 13; 236(24):2775-6. PubMed ID: 1036572
    [Abstract] [Full Text] [Related]

  • 5. Life-threatening hyperkalemia: a complication of spironolactone for heart failure in a patient with renal insufficiency.
    Hu Y, Carpenter JP, Cheung AT.
    Anesth Analg; 2002 Jul 13; 95(1):39-41, table of contents. PubMed ID: 12088939
    [Abstract] [Full Text] [Related]

  • 6. Hyperkalemia during spironolactone use in patients with decompensated heart failure.
    Lima MV, Ochiai ME, Cardoso JN, Morgado PC, Munhoz RT, Barretto AC.
    Arq Bras Cardiol; 2008 Sep 13; 91(3):177-82, 194-9. PubMed ID: 18853060
    [Abstract] [Full Text] [Related]

  • 7. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M, Takada M, Hirooka K, Isobe F, Yasumura Y.
    J Clin Pharm Ther; 2005 Dec 13; 30(6):603-10. PubMed ID: 16336294
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Spironolactone and potassium].
    Kjeldsen K.
    Ugeskr Laeger; 2004 Nov 22; 166(48):4392; author reply 4392-3. PubMed ID: 15587639
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure.
    Shah KB, Rao K, Sawyer R, Gottlieb SS.
    J Am Coll Cardiol; 2005 Sep 06; 46(5):845-9. PubMed ID: 16139135
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.